These lessons and experiences are learned and shared mostly through webinars and computer-assisted data collection, according to Dr. Rontgene Solante, chair of the Adult Infectious Disease and Tropical Medicine section of San Lazaro Hospital in Manila.
Solante said new guidelines for patient care were made “in collaboration” with the Philippine College of Chest Physicians, which also gets guidelines and references from the American College of Chest Physicians.He and fellow infectious disease specialists constantly check with and collate data from the Infectious Disease Society of America on managing COVID-19 patients.
But medical journals report that the drug inhibits viral replication. In a webinar series on patient care, Solante reported that San Lazaro had been using remdesivir as part of the solidarity clinical trial of COVID-19 treatments. “We observed that if you give it late, there are already so many complications. So we created a new protocol where we try to give it earlier, even to those who are moderately ill. It was found out that the sooner you give it, within the 14 days, that’s the best time to give the convalescent plasma,” he said.
Solante said Philippine physicians use remdesivir and dexamethasone following updated clinical guidelines from abroad and WHO. “In COVID-19, it’s very important that you try to pinpoint the problems right away so that you don’t allow it to progress to a point that complications may set in,” he added. Del Rosario himself used that machine, which delivers a higher flow of oxygen to the lungs through the nose.
'UP kase alam lang mag rally'
Roque /Doque, this is the reason you have 2% IDR despite the 200K cases, and you still give higher pay to death, not peace bringers rather than HCWs, no thanks to this government.